C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2011
11/02/2011	EP2381788A2 Targeted cryptosporidium biocides
11/02/2011	EP2126136B1 Diagnosis of prostate cancer
11/02/2011	EP1836225B1 Kir-binding agents and methods of use thereof
11/02/2011	EP1755659B1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
11/02/2011	EP1730194B1 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	EP1572746B1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
11/02/2011	EP1508043B1 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl
11/02/2011	EP1425389B1 Human antibodies specific for interleukin 15 (il-15)
11/02/2011	EP1311290B1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
11/02/2011	EP1071710B2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
11/02/2011	EP1034298B1 Humanization of murine antibody
11/02/2011	CN1753912B Antibodies against PD-1 and uses therefor
11/02/2011	CN102232088A Anti-PCSK9 and methods for treating lipid and cholesterol disorders
11/02/2011	CN102232087A Antibodies to modified human IGF-1/E peptides
11/02/2011	CN102232086A Process for the modulation of the antagonistic activity of a monoclonal antibody
11/02/2011	CN102229915A EV71 virus monoclonal antibody, hybridoma cell line and application
11/02/2011	CN102229914A Monoclonal antibody of anti-BDV (Borna disease virus) nucleoprotein, and its preparation method and application
11/02/2011	CN102229913A Test strip for rapidly detecting plasmodia based on colloidal gold immunochromatographic assay, as well as antibodies and cell lines thereof
11/02/2011	CN102229672A Single-chain antibody against fenitrothion and preparation method thereof
11/02/2011	CN102229671A Anti-IMMT anthropogenic Fab antibody and application thereof in preparing anti-liver cancer drugs
11/02/2011	CN102229670A Method for extracting immune globulin from yak blood
11/02/2011	CN102229658A Anti-rheumatoid arthritis polypeptide and its application in pharmacy
11/02/2011	CN102229657A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229656A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229655A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229654A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229653A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229652A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN101818129B Hybridoma cell line for anti-African swine fever virus monoclonal antibody and monoclonal antibody secreted thereby
11/02/2011	CN101531718B Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof
11/01/2011	US8049001 Probe, probe set, probe carrier, and testing method
11/01/2011	US8048995 Human skeletal muscle-specific ubiquitin-conjugating enzyme
11/01/2011	US8048994 C-type lectin polypeptide, polynucleotide and methods of making and use thereof
11/01/2011	US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011	US8048992 Anti-IgSF4 antibody and utilization of the same
11/01/2011	US8048991 Antibody to an integrin heterodimer and/or a subunit thereof
11/01/2011	US8048987 Polypeptides having DNA polymerase activity
11/01/2011	US8048984 Human GIL-19/AE289 proteins
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048635 Measurement of soluble Tweak levels for evaluation of lupus patients
11/01/2011	US8048422 Tweak binding antibodies
11/01/2011	US8048417 Anti-human tenascin monoclonal antibody
11/01/2011	US8048415 Compositions and methods for promoting or inhibiting angiogenesis
11/01/2011	US8048414 Antivenom composition containing Fab fragments
11/01/2011	CA2494140C Specific antibodies for diagnosing heart failure
11/01/2011	CA2452986C Use of polyclonal anti-hiv goat serum as a therapeutic agent
11/01/2011	CA2450231C System and method for the large scale labeling of compounds with radiohalogens
11/01/2011	CA2447602C Anti-trail-r antibodies
11/01/2011	CA2396718C Pre-transplant accomodated organs resistant to anti-donor immunity
11/01/2011	CA2376299C Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
11/01/2011	CA2279196C Antigenic inducer and substances prepared therefrom
11/01/2011	CA2105903C Methods and compositions for the detection of soluble .beta.-amyloid peptide
10/2011
10/27/2011	WO2011133931A1 Use of il-27 antagonists for treating inflammatory bowel disease
10/27/2011	WO2011133919A1 Use of tau to monitor immunotherapy
10/27/2011	WO2011133886A2 Production of heteromultimeric proteins
10/27/2011	WO2011133429A1 Cancer-related glycopeptide epitopes, antibodies and methods of use
10/27/2011	WO2011131980A1 Assay for identification of lrrk2 inhibitors
10/27/2011	WO2011131746A2 Heterodimeric antibody fc-containing proteins and methods for production thereof
10/27/2011	WO2011131659A2 Binding domains
10/27/2011	WO2011131407A1 Antibodies against human csf-1r and uses thereof
10/27/2011	WO2011131178A2 Method for detecting a salmonella infection
10/27/2011	WO2011130801A1 Wheat immunoreactivity
10/27/2011	WO2011112566A3 Basigin binding proteins
10/27/2011	WO2011109112A3 Method of detecting tau protein and tau fragments in serum
10/27/2011	WO2011103490A3 INTEGRIN αVβ8 NEUTRALIZING ANTIBODY
10/27/2011	WO2011092593A3 Hiv-1 neutralizing antibodies and uses thereof
10/27/2011	WO2011081421A9 Complement c9 as markers for the diagnosis of cancer
10/27/2011	WO2011074802A3 Kit for diagnosing prostate cancer and diagnosis method
10/27/2011	WO2011068870A3 Modulation of nk cell antigen specific effector activity by modulation of cxcr6 (cd186)
10/27/2011	WO2011066503A3 Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
10/27/2011	WO2011039511A3 Agents, uses and methods
10/27/2011	WO2011039510A3 Conjugates targeting the cd163 receptor
10/27/2011	WO2010115589A8 Trivalent, bispecific antibodies
10/27/2011	US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011	US20110263833 Compositions for isolating a target analyte from a heterogeneous sample
10/27/2011	US20110263832 Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides
10/27/2011	US20110263831 NUCLEAR FACTOR kappaB INDUCING FACTOR
10/27/2011	US20110263830 Process for the modulation of the antagonistic activity of a monoclonal antibody
10/27/2011	US20110263829 Cell-penetrating, sequence-specific and nucleic acid-hydrolyzing antibody, method for preparing the same and pharmaceutical composition comprising the same
10/27/2011	US20110263828 Methods for modifying human antibodies by glycan engineering
10/27/2011	US20110263827 Dual Variable Domain Immunnoglobulins and Uses Thereof
10/27/2011	US20110263826 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals
10/27/2011	US20110263825 Anti-cd20 monoclonal antibodies
10/27/2011	US20110263821 Prognosis and risk assessment in stroke patients by determining the level of marker peptides
10/27/2011	US20110263679 C12orf48 as a target gene for cancer therapy and diagnosis
10/27/2011	US20110263485 Bifunctional Griffithsin Analogs
10/27/2011	US20110263482 Complement inhibitors
10/27/2011	US20110263436 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same
10/27/2011	US20110262992 Method for stabilizing labeled antibody
10/27/2011	US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer
10/27/2011	US20110262963 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
10/27/2011	US20110262944 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus
10/27/2011	US20110262938 Determination of the amount of hLHB core fragment in a sample from a subject and uses thereof
10/27/2011	US20110262933 Compositions and method for isolating mid-log phase bacteria
10/27/2011	US20110262932 Compositions
10/27/2011	US20110262929 Anti-hs6st2 antibodies and uses thereof
10/27/2011	US20110262897 Imaging techniques using a tridentate ligand
10/27/2011	US20110262893 Separating target analytes using alternating magnetic fields

1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 1494